| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10744 | 2021 |
| Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C Y Tanaka, N Nishida, M Sugiyama, M Kurosaki, K Matsuura, N Sakamoto, ... Nature genetics 41 (10), 1105-1109, 2009 | 2769 | 2009 |
| Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan E Orito, T Ichida, H Sakugawa, M Sata, N Horiike, K Hino, K Okita, ... Hepatology 34 (3), 590-594, 2001 | 596 | 2001 |
| Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C A Kasahara, N Hayashi, K Mochizuki, M Takayanagi, K Yoshioka, ... Hepatology 27 (5), 1394-1402, 1998 | 576 | 1998 |
| Japan Society of Hepatology guidelines for sarcopenia in liver disease: Recommendation from the working group for creation of sarcopenia assessment criteria H Nishikawa, M Shiraki, A Hiramatsu, K Moriya, K Hino, S Nishiguchi Hepatology Research 46 (10), 951-963, 2016 | 572 | 2016 |
| Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma … M Kudo, K Ueshima, M Ikeda, T Torimura, N Tanabe, H Aikata, N Izumi, ... Gut 69 (8), 1492-1501, 2020 | 558 | 2020 |
| Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection A Ozasa, Y Tanaka, E Orito, M Sugiyama, JH Kang, S Hige, T Kuramitsu, ... Hepatology 44 (2), 326-334, 2006 | 315 | 2006 |
| Hepatitis C virus–induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription S Nishina, K Hino, M Korenaga, C Vecchi, A Pietrangelo, Y Mizukami, ... Gastroenterology 134 (1), 226-238, 2008 | 311 | 2008 |
| Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a … M Kudo, K Ueshima, O Yokosuka, S Ogasawara, S Obi, N Izumi, H Aikata, ... The lancet Gastroenterology & hepatology 3 (6), 424-432, 2018 | 267 | 2018 |
| Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open‐label, phase 3 trial M Omata, S Nishiguchi, Y Ueno, H Mochizuki, N Izumi, F Ikeda, H Toyoda, ... Journal of Viral Hepatitis 21 (11), 762-768, 2014 | 238 | 2014 |
| Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein T Furutani, K Hino, M Okuda, T Gondo, S Nishina, A Kitase, M Korenaga, ... Gastroenterology 130 (7), 2087-2098, 2006 | 198 | 2006 |
| Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease M Abe, T Miyake, A Kuno, Y Imai, Y Sawai, K Hino, Y Hara, S Hige, ... Journal of gastroenterology 50, 776-784, 2015 | 183 | 2015 |
| Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean N Nishida, H Sawai, K Matsuura, M Sugiyama, SH Ahn, JY Park, S Hige, ... PloS one 7 (6), e39175, 2012 | 165 | 2012 |
| Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A K Matsuura, Y Tanaka, S Hige, G Yamada, Y Murawaki, M Komatsu, ... Journal of clinical microbiology 47 (5), 1476-1483, 2009 | 145 | 2009 |
| Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver M Okuda, K Hino, M Korenaga, Y Yamaguchi, Y Katoh, K Okita Hepatology 29 (1), 217-222, 1999 | 141 | 1999 |
| Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver‐related death A Kasahara, H Tanaka, T Okanoue, Y Imai, H Tsubouchi, K Yoshioka, ... Journal of Viral Hepatitis 11 (2), 148-156, 2004 | 103 | 2004 |
| Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for … Y Tanaka, M Kurosaki, N Nishida, M Sugiyama, K Matsuura, N Sakamoto, ... Human molecular genetics 20 (17), 3507-3516, 2011 | 100 | 2011 |
| Endoscopic ligation of gastric varices using a detachable snare T Yoshida, N Hayashi, N Suzumi, S Miyazaki, S Terai, T Itoh, S Nishimura, ... Endoscopy 26 (05), 502-505, 1994 | 98 | 1994 |
| Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma T Kawase, Y Yasui, S Nishina, Y Hara, I Yanatori, Y Tomiyama, ... BMC gastroenterology 15, 1-9, 2015 | 97 | 2015 |
| The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese … K Ito, K Higami, N Masaki, M Sugiyama, M Mukaide, H Saito, Y Aoki, ... Journal of clinical microbiology 49 (5), 1853-1860, 2011 | 91 | 2011 |
